Clinical and Vaccine Immunology

Aims & Scope

Cessation.

First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology.

CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Correlates of Protection Induced by Vaccination

  Citation: 1483

  Authors: Stanley A.

• The Probiotic Bacterium <i>Lactobacillus casei</i> Induces Activation of the Gut Mucosal Immune System through Innate Immunity

  Citation: 445

  Authors: C. Maldonado, G.

• The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench

  Citation: 360

  Authors: Melanie C., Viktor, Christine, Gerald, Esther, Nancy, Stephen, Yvonne, Susan, Kathleen, Mary A.

• The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-κβ System

  Citation: 303

  Authors: Madhavan P., Supriya, Jessica L., Ravikumar, Harikrishnan, Stanley A., Chithan

• Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents

  Citation: 291

  Authors: Roberto, Hiroki, Lili, Robert, Jianping, David, Mark L., James M.

• <i>Escherichia coli</i>and<i>Staphylococcus aureus</i>Elicit Differential Innate Immune Responses following Intramammary Infection

  Citation: 288

  Authors: Douglas D., Max J., Jai-Wei, Xin, Jayne C., Pascal

• <i>In Vitro</i> Experimental Model of Trained Innate Immunity in Human Primary Monocytes

  Citation: 281

  Authors: Siroon, Bastiaan A., Leo A. B., Niels P., Reinout, Mihai G.

• Trained Immunity or Tolerance: Opposing Functional Programs Induced in Human Monocytes after Engagement of Various Pattern Recognition Receptors

  Citation: 277

  Authors: Daniela C., Jessica, Leo A. B., Cor, Trees, Liesbeth, Neil A. R., David L., Jos W. M., Mihai G.

• Targeting the “Cytokine Storm” for Therapeutic Benefit

  Citation: 274

  Authors: Riccardo V., Kate, Petra C., Roman A., Graeme C.

• Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza

  Citation: 271

  Authors: Victor C., Raelene M., Martha N., Laura A., Rachael, Scott A., Natalia, Daniel R., Gene H., Jonathan A.